79 related articles for article (PubMed ID: 28084089)
1. Metabolic changes in rat serum after administration of suberoylanilide hydroxamic acid and discriminated by SVM.
Yu J; Wu H; Lin Z; Su K; Zhang J; Sun F; Wang X; Wen C; Cao H; Hu L
Hum Exp Toxicol; 2017 Dec; 36(12):1286-1294. PubMed ID: 28084089
[TBL] [Abstract][Full Text] [Related]
2. Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities.
Lin K; Zhang Q; Liu Z; Yang S; Lin Y; Wen C; Zheng Y
Int J Clin Exp Pathol; 2015; 8(5):5584-90. PubMed ID: 26191268
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction study combining lapatinib with vorinostat in rats.
Lin F; Wang S; Zhou Y; Wu C; Zou H; Geng P; Zhang Q; Zhang X
Pharmacology; 2015; 95(3-4):160-5. PubMed ID: 25896603
[TBL] [Abstract][Full Text] [Related]
4. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
Butler LM; Agus DB; Scher HI; Higgins B; Rose A; Cordon-Cardo C; Thaler HT; Rifkind RA; Marks PA; Richon VM
Cancer Res; 2000 Sep; 60(18):5165-70. PubMed ID: 11016644
[TBL] [Abstract][Full Text] [Related]
5. Serum metabolic changes in rats after intragastric administration of dextromethorphan.
Bao S; Zhang J; Lin Z; Su K; Mo J; Hong L; Qian S; Chen L; Sun F; Wen C; Wu Q; Hu L; Lin G; Wang X
Biomed Chromatogr; 2017 Mar; 31(3):. PubMed ID: 27528536
[TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
[TBL] [Abstract][Full Text] [Related]
7. Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbits.
Wise LD; Turner KJ; Kerr JS
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):57-68. PubMed ID: 17294457
[TBL] [Abstract][Full Text] [Related]
8. Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex.
Kim JY; Shim G; Choi HW; Park J; Chung SW; Kim S; Kim K; Kwon IC; Kim CW; Kim SY; Yang VC; Oh YK; Byun Y
Biomaterials; 2012 Jun; 33(17):4424-30. PubMed ID: 22425551
[TBL] [Abstract][Full Text] [Related]
9. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
10. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.
Liao B; Liang H; Chen J; Liu Q; Zhang B; Chen X
Tumour Biol; 2015 Dec; 36(12):9347-56. PubMed ID: 26108995
[TBL] [Abstract][Full Text] [Related]
11. Assessment of female and male fertility in Sprague-Dawley rats administered vorinostat, a histone deacetylase inhibitor.
Wise LD; Spence S; Saldutti LP; Kerr JS
Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):19-26. PubMed ID: 18092367
[TBL] [Abstract][Full Text] [Related]
12. Metabolic changes in rat urine after acute paraquat poisoning and discriminated by support vector machine.
Wen C; Wang Z; Zhang M; Wang S; Geng P; Sun F; Chen M; Lin G; Hu L; Ma J; Wang X
Biomed Chromatogr; 2016 Jan; 30(1):75-80. PubMed ID: 26419410
[TBL] [Abstract][Full Text] [Related]
13. Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo.
Eyüpoglu IY; Hahnen E; Buslei R; Siebzehnrübl FA; Savaskan NE; Lüders M; Tränkle C; Wick W; Weller M; Fahlbusch R; Blümcke I
J Neurochem; 2005 May; 93(4):992-9. PubMed ID: 15857402
[TBL] [Abstract][Full Text] [Related]
14. Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin 43 gene locus.
Ogawa T; Hayashi T; Tokunou M; Nakachi K; Trosko JE; Chang CC; Yorioka N
Cancer Res; 2005 Nov; 65(21):9771-8. PubMed ID: 16266998
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of co-treatment with suberoylanilide hydroxamic acid and mitomycin C on corneal scarring after therapeutic keratectomy: an animal study.
Woo JE; Park WC; Yoo YH; Kim SW
Curr Eye Res; 2014 Apr; 39(4):348-58. PubMed ID: 24401036
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of suberoylanilide hydroxamic acid (Vorinostat) in the treatment of canine corneal fibrosis.
Bosiack AP; Giuliano EA; Gupta R; Mohan RR
Vet Ophthalmol; 2012 Sep; 15(5):307-14. PubMed ID: 22212187
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
18. Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.
Bali P; Pranpat M; Swaby R; Fiskus W; Yamaguchi H; Balasis M; Rocha K; Wang HG; Richon V; Bhalla K
Clin Cancer Res; 2005 Sep; 11(17):6382-9. PubMed ID: 16144943
[TBL] [Abstract][Full Text] [Related]
19. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
Jiang X; Tsang YH; Yu Q
Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
[TBL] [Abstract][Full Text] [Related]
20. Effects and mechanism of suberoylanilide hydroxamic acid on the proliferation and apoptosis of human hepatoma cell line Bel-7402.
Wang YC; Kong WZ; Xing LH; Yang X
J BUON; 2014; 19(3):698-704. PubMed ID: 25261655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
